Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04678817 · ClinicalTrials.gov registry record
Same Day Oral EC and Implant Initiation
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 306
- Enrollment target
NCT04678817: Completed study, sponsored by University of Utah.
NCT04678817 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 306 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04678817 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 306 participants
- Enrollment target
Study Summary
This is a study for clients presenting for emergency contraception (EC). EC is used to prevent pregnancy after unprotected intercourse. Clients presenting for EC may be offered either the copper or hormonal IUD or oral EC. Current guidelines allow for same-day implant initiation at the time of an EC encounter, as long as oral LNG EC is co-administered. This study will look at pregnancy rates and clients willingness to receive same-day implant + oral EC and same-day IUDs.
Primary Outcome
To determine a point estimate for the one-month pregnancy rate following guideline supported same-day initiation of an etonogestrel (ENG) implant plus oral levonorgestrel (LNG) emergency contraception (EC).
Interventions
- DEVICE Etonogestrel contraceptive implant with oral levonorgestrel
- DEVICE Levonorgestrel intrauterine device
- DEVICE Copper T380A intrauterine device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 306 participants |
| Start Date | 2021-02-17 |
| Est. Completion | 2024-03-15 |
What the finished NCT04678817 record still lists
NCT04678817 is an observational study that tracks outcomes without assigning an intervention. The registered 306 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Etonogestrel contraceptive implant with oral levonorgestrel is the first listed.
NCT04678817 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04678817 about?
NCT04678817 is a clinical study titled "Same Day Oral EC and Implant Initiation". This is a study for clients presenting for emergency contraception (EC). EC is used to prevent pregnancy after unprotected intercourse. Clients presenting for EC may be offered either the copper or hormonal IUD or oral EC. Current guidelines allow for same-day implant initiation at the time of an EC...
What is the current status of trial NCT04678817?
This trial is currently completed. The enrollment target is 306 participants. The study started on 2021-02-17. Estimated completion is 2024-03-15.
What interventions are being tested in trial NCT04678817?
The interventions under investigation include: Etonogestrel contraceptive implant with oral levonorgestrel (DEVICE), Levonorgestrel intrauterine device (DEVICE), Copper T380A intrauterine device (DEVICE).
Who is sponsoring clinical trial NCT04678817?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05078970 · 306 participants · NA
Advancing Suicide Intervention Strategies for Teens During High Risk Periods
- NCT05843695 · 306 participants · NA
Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety
- NCT06057337 · 306 participants · NA
Families With Pride ("Familias Con Orgullo").
- NCT06498635 · 306 participants · Phase 3
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI